IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets

IF 4.5 3区医学 Q2 IMMUNOLOGY

Vaccine Pub Date : 2024-10-02 DOI:10.1016/j.vaccine.2024.126400

Suzanne M. Garland , Neerja Bhatla , Yin Ling Woo

引用次数: 0

Abstract

The global supply of human papillomavirus (HPV) prophylactic vaccines has been constrained since 2020.Vaccine manufacturers have increased capacity and new HPV vaccines are now available. Vaccine supply is now able to meet the full HPV vaccine demand which has been achieved earlier than predicted.

查看原文本刊更多论文

IPVS 关于 HPV 疫苗接种的声明：供应不再受限：实现世卫组织疫苗目标。

自 2020 年以来，全球人类乳头瘤病毒 (HPV) 预防性疫苗的供应一直受到限制。疫苗生产商提高了产能，新的 HPV 疫苗现已上市。疫苗供应现在能够满足全部的 HPV 疫苗需求，这比预测的时间提前了。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccine 医学-免疫学

CiteScore

8.70

自引率

5.50%

发文量

992

审稿时长

131 days

期刊介绍： Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.